On July 9, President Obama signed the bipartisan Food and Drug Administration Safety and Innovation Act, that reauthorizes FDA user fees and that will establish new user-fee programs for biosimilar drugs. Read more.
Media Room
President Obama Signs FDA User Fee Bill
Tuesday, July 10th, 2012